Stock Sale, Buyback News

Stay updated with the latest stock sale and buyback news. Read about company stock transactions, buyback programs, market impacts, and investor reactions. Discover how these financial moves influence stock prices and shareholder value.

Aug 11, 2026 at 2:36 AM

Intel Announces Upsize and Pricing of $20 Billion Common Stock Offering

SANTA CLARA, Calif.--(BUSINESS WIRE)--Intel Corporation (Nasdaq: INTC) today announced the pricing of its previously announced registered public offering of common stock. Intel priced the underwritten public offering of 210,526,315 shares of common stock at a public offering price of $95 per share. Intel has granted to the underwriters a 30-day option to purchase up to 31,578,947 additional shares of common stock at the public offering price, less underwriting discounts. The offering was upsize...
Aug 11, 2026 at 2:00 AM

TotalEnergies SE: Disclosure of Transactions in Own Shares

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from August 3 to August 7, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/...
Aug 10, 2026 at 4:30 PM

Curtiss-Wright Announces $100 Million Expansion of 2026 Share Repurchase Program

DAVIDSON, N.C.--(BUSINESS WIRE)--Curtiss-Wright Corporation announced $100M expansion of its 2026 share repurchase program, now expected to result in annual share repurchases of $160M...
Aug 10, 2026 at 4:05 PM

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 46,044 shares of its common stock to 149 new non-executive employees with a grant date of August 3, 2026, under the Guardant Health, Inc. 2023 Employment Inducement Incentive Award Plan (the “Inducement Plan”). The RSUs...
Aug 10, 2026 at 4:04 PM

American Healthcare REIT Announces Public Offering of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today that it has commenced an underwritten public offering of 13,250,000 shares of its common stock on a forward basis in connection with the forward sale agreements described below. Morgan Stanley, Citigroup and KeyBanc Capital Markets are acting as the joint book-running managers for the offering. In connection with the offering, the Company expects to enter into forward sale agreements with...
Aug 10, 2026 at 4:01 PM

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of approximately $150 million of its American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the United States. The proposed offering is a public offering registered under th...
Aug 10, 2026 at 11:45 AM

Eurofins Scientific SE: Weekly Report on Share Repurchases from 03rd August to 07th August 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/08/2026 FR0014000MR3 20 000 68.4085 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 04/08/2026 FR0014000MR3 20 000 68.6892 XPAR EUROFINS SCIENTIFIC 529900JEHFM...
Aug 10, 2026 at 8:50 AM

Lincoln Financial Announces Offers to Purchase Up To $500 Million Aggregate Liquidation Preference of Its Series C and Series D Depositary Shares

RADNOR, Pa.--(BUSINESS WIRE)--Lincoln Financial (NYSE: LNC) today announced the commencement by Lincoln National Corporation (the “Company”) of concurrent but separate offers (each, an “Offer” and, together, the “Offers”) to purchase for cash up to $500 million in aggregate Liquidation Preference (as defined below) (such amount, the “Maximum Aggregate Liquidation Preference”) of its outstanding depositary shares, representing fractional interests in certain series of its preferred stock, listed...
Aug 10, 2026 at 7:45 AM

Intel Announces Proposed $15 Billion Common Stock Offering

SANTA CLARA, Calif.--(BUSINESS WIRE)--Intel intends to use net proceeds from the proposed stock offering for general corporate purposes and to enable growth opportunities....
Aug 10, 2026 at 7:00 AM

Lincoln National Corporation’s Board of Directors Declares Quarterly Cash Dividend & Announces Plans to Resume Share Repurchases in the Third Quarter of 2026

RADNOR, Pa.--(BUSINESS WIRE)--Lincoln Financial (NYSE: LNC) announced today that the board of directors of Lincoln National Corporation declared a quarterly cash dividend of $0.45 per share on the company’s common stock. The dividend on the common stock will be payable November 2, 2026, to shareholders of record at the close of business on October 12, 2026. The company also announced that it intends to resume repurchasing shares of its common stock this quarter. Any repurchases will be made pur...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up